Join Azzur Group in Vancouver, Canada!
Starting May 29th is the ISCT 2024 Annual Meeting where global experts gather together to collaborate on insights, solutions, and trends happening in the cell and gene therapy industry.
Don’t miss Javier Cardenas, Ph.D., Senior Consultant, Azzur Group, as he presents in the Poster Hall on Wednesday, May 29th, 7:00 - 8:30 PM.
Managing Risk in Advanced Therapy Manufacturing: Navigating the Challenges from Rapid Development to cGMP Compliance
May 29th, 2024 at 7:00 - 8:30 PM
Javier Cardenas, Ph.D., Senior Consultant, Azzur Group
What You’ll Learn from Dr. Cardenas:
- The intricacies of ensuring quality in advanced therapy manufacturing, spanning from rapid development to cGMP compliance.
- How to address challenges such as accelerated timelines and production scale-up, emphasizing the importance of proactive risk management.
- Strategies encompassing material qualification, facility design, and process scalability.
- Embedding risk management at all organizational levels to foster sustained quality and compliance throughout the therapy lifecycle.
About About Javier Cardenas, Ph.D.:
Javier Cardenas, Ph.D. is a Senior Consultant at Azzur Group. In this role, Dr. Cardenas facilitates increased compliance of sterile injectables, medical devices, and biologics manufacturing facilities through Commissioning, Qualification, and Validation (CQV) efforts in the Southern California region. Having received his graduate degree in Molecular Biotechnology at the University of California – Irvine, his passion is driving technical advancements and knowledge in the Cell & Gene Therapy space.
Check out his article on how CGT innovators can overcome challenges as they work to bring their therapies to market.